Last reviewed · How we verify

NCT05219344: MF2-TMG-CMJ

Tissue Flossing and Lower Limb Neuromuscular Function

Completed NA Last updated 11 January 2024
What this trial tests

NA trial testing Tissue flossing in Physical Performance in 19 participants. Completed in 1 December 2021.

Timeline
20 May 2021
Primary endpoint
25 October 2021
1 December 2021

Quick facts

Lead sponsorUniversity of Ljubljana
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment19
Start date20 May 2021
Primary completion25 October 2021
Estimated completion1 December 2021
Sites1 location across Slovenia

Drugs / interventions tested

Conditions studied

Sponsor

University of Ljubljana

Who can join

Adults 18 to 35, male only, with Physical Performance or Neuromuscular Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no study investigating different volumes, that is various sets of the configuration of tissue flossing on neuromuscular function. Previously, investigators found that 3 sets of TF impaired neuromuscular function assessed with TMG. Therefore, the aim is to compare the effects of one and two sets of TS on countermovement jump (CMJ) performance and muscle contractile properties.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Tissue flossing

Trials testing the same drug.

Other recruiting trials for Physical Performance

Currently open trials in the same condition.

Other University of Ljubljana trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05219344.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing